GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acrux Ltd (OTCPK:ARUXF) » Definitions » Change In Receivables

Acrux (ARUXF) Change In Receivables : $0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Acrux Change In Receivables?

Acrux's change in receivables for the quarter that ended in Dec. 2024 was $0.00 Mil. It means Acrux's Accounts Receivable stayed the same from Jun. 2024 to Dec. 2024 .

Acrux's change in receivables for the fiscal year that ended in Jun. 2024 was $0.00 Mil. It means Acrux's Accounts Receivable stayed the same from Jun. 2023 to Jun. 2024 .

Acrux's Accounts Receivable for the quarter that ended in Dec. 2024 was $0.87 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Acrux's Days Sales Outstanding for the six months ended in Dec. 2024 was 2,098.75.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Acrux's liquidation value for the six months ended in Dec. 2024 was $-0.01 Mil.

Acrux Change In Receivables Historical Data

The historical data trend for Acrux's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acrux Change In Receivables Chart

Acrux Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Acrux Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Acrux Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acrux  (OTCPK:ARUXF) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Acrux's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0.874/0.076*91
=2,098.75

2. In Ben Graham's calculation of liquidation value, Acrux's accounts receivable are only considered to be worth 75% of book value:

Acrux's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=2.106-2.775+0.75 * 0.874+0.5 * 0
=-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acrux Change In Receivables Related Terms

Thank you for viewing the detailed overview of Acrux's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Acrux Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acrux Ltd (OTCPK:ARUXF) » Definitions » Change In Receivables
Comparable Companies
ASX:MEM ASX:1AI ASX:CHM ASX:NSB ASX:PAB ASX:AVE ASX:TRP ASX:CMB ASX:IXC ASX:BGT VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
FJY:Germany ACR:Australia
Address
103-113 Stanley Street, West Melbourne, Melbourne, VIC, AUS, 3003
Website
https://www.acrux.com.au
Acrux Ltd is a pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. The group is formulating and developing a range of topical generic products by leveraging its skilled workforce, on-site laboratories, GMP manufacturing suite, and technical, clinical, and commercial experience to bring affordable products to market. Geographically, it has a presence in Australia; the United States; Europe, and other countries. The firm operates in a single segment and derives revenue from developing and commercializing pharmaceutical products that administer drugs topically. Its product pipeline products include Lenzetto, Evamist, Testosterone Topical Solution, and among others.